Research carried out by RCSI University of Medicine and Health Sciences has revealed new information about how blood clots are formed during wound healing.

The research, published tomorrow in Science Advances, examines the behaviour of platelets at a wound site, specifically their ability to sense where within a blood clot they are and remodel their surroundings accordingly.

Platelets are key to initiating wound healing and the formation of blood clots (thrombus). Fibroblasts are connective tissue cells that are essential for the later stages of wound healing. Fibroblasts invade the clot that has been formed and produce vital proteins, including fibronectin, that then forma structural framework to build the new tissue needed to heal.

This new study indicates that platelets can also form a provisional fibronectin matrix in their surroundings, similar to what fibroblasts do in the later stages of wound healing. This has potential implications for how the integrity of blood clots might be maintained during vascular repair.

The study’s lead author is Dr Ingmar Schoen from the School of Pharmacy and Biomolecular Sciences at RCSI.

Commenting on the discovery, Dr Schoen said: “We have identified an additional unexpected role for the most prominent platelet adhesion receptor. Our results show that platelets not only form the clot but also can initiate its remodelling by erecting a fibrous scaffold. This finding challenges some existing paradigms in the field of wound healing, which is dominated by research on fibroblasts.”

Key to this research was the use of superresolution microscopy, which enables sharper images of structures inside or around cells to be captured and observed in vitro, in a laboratory. Observation of this platelet behaviour in a living organism (in vivo) will be required to further develop this finding.

“Without super-resolution microscopy, this discovery would not have been possible,” Dr Schoen noted.

The research was carried out in collaboration with researchers at ETH Zurich, Julius-Maximilians-University Würzburg, University of Freiburg and University Hospital Zurich.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What color is the sky on a sunny day?

Explore More

Just a moment…

Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until

Novel low-dose triple single-pill combination shows efficacy and tolerability in two international trials

Credit: Unsplash/CC0 Public Domain A low-dose triple single-pill combination was effective at lowering blood pressure (BP) in two trials presented in a Hot Line session today at ESC Congress 2024.

Effects and consequences of cardiac metabolism in the elderly

Alterations in cardiac metabolic homeostasis occurred with aging. The capability of metabolic adatpive response to pathological stress conditions declines in the aged heart. The pharmacologica and non-pharmacological approaches could rescue